EMvision Research Notes, page-1092

I just want to thank the posters on this site for all the good work you are doing. I enjoy reading all the posts. I even enjoy The Brown Hornet because every group needs a trickster.

My friend introduced me to EMV in January this year and my intuition yelled buy. Of course I checked it out and the deeper I checked the better it got. I started buying in late January and I have been buying consistently ever since. I now own 836,000 shares and I am still buying especially on down days. I shall continue to buy until the share price is heading north. I cannot predict when this will happen but I imagine FDA Breakthrough Status will give the share price a good lift. We should have more information in the quarterly report due next week.

I revisited my share price forecast in my post on 1st April. Since then there has been positives and negatives. The positives are a higher sale price for Gen1 device of around $200,000 rather than the $100,000 I assumed. There has also been improvements in software and hardware. The negative is the commercialization of Gen2 device looks to be delayed as our company concentrates on getting Gen1 to market. I am now assuming it will be on sale in 2024.

Swings and roundabouts so I am sticking to my forecast of $25 by the end of 2023.